Elevation of C-reactive protein during concurrent chemoradiotherapy is a poor predictive factor for head and neck cancer.
Masahiro AdachiMasahiro NakayamaShin MatsumotoYoshihide ShimaIsao UemaetomariTomonori YoshimuraKayoko OnishiMasamitsu SenaritaKeiji TabuchiPublished in: Auris, nasus, larynx (2023)
Elevated CRP levels after the first cycle of cisplatin is an objective predictive marker for survival in patient with head and neck squamous cell carcinoma treated with CCRT.